Impact of Delayed Video-Assisted Thoracoscopic Surgery on Pneumonectomy Outcomes in Patients with Tuberculosis
Objective: To investigate the impact of delayed video-assisted thoracoscopic surgery (VATS) on the rate of postoperative complications and tuberculosis recurrence following pneumonectomy.Materials and methods: A retrospective, open, cohort, nonrandomized, multicenter study conducted between 1984 and...
| Published in: | Инновационная медицина Кубани |
|---|---|
| Main Authors: | D. B. Giller, V. A. Basangova, O. Sh. Kesaev, S. S. Saenko, Sh. E. Mayusupov, B. I. Nasritdinov, E. F. Ermakov, M. S. Shogenov, E. V. Glukhov, A. A. Filatov, I. A. Dadyev, A. E. Ergeshov |
| Format: | Article |
| Language: | English |
| Published: |
Scientific Research Institute, Ochapovsky Regional Clinical Hospital no. 1
2025-05-01
|
| Subjects: | |
| Online Access: | https://www.innovmedkub.ru/jour/article/view/1192 |
Similar Items
Prevention of bronchial fistulas after pneumonectomies for selected cavitary drug resistant lung tuberculosis
by: Alexander V. Bazhenov, et al.
Published: (2023-03-01)
by: Alexander V. Bazhenov, et al.
Published: (2023-03-01)
Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort studyResearch in context
by: Yousra Kherabi, et al.
Published: (2025-09-01)
by: Yousra Kherabi, et al.
Published: (2025-09-01)
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
by: Viola Dreyer, et al.
Published: (2022-08-01)
by: Viola Dreyer, et al.
Published: (2022-08-01)
Pretomanid for tuberculosis treatment: an update for clinical purposes
by: Sara Occhineri, et al.
Published: (2022-01-01)
by: Sara Occhineri, et al.
Published: (2022-01-01)
Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil
by: Tania Matsui, et al.
Published: (2020-05-01)
by: Tania Matsui, et al.
Published: (2020-05-01)
Prevalence of Pre-Extensively Drug-Resistant Tuberculosis (Pre XDR-TB) and Extensively Drug-Resistant Tuberculosis (XDR-TB) among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Center in Mumbai
by: Unnati D. Desai, et al.
Published: (2016-07-01)
by: Unnati D. Desai, et al.
Published: (2016-07-01)
Multidrug-Resistant Tuberculosis In A Referral Center In Rome: 2011– 2016
by: Cannas A, et al.
Published: (2019-10-01)
by: Cannas A, et al.
Published: (2019-10-01)
Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France
by: Isabelle Bonnet, et al.
Published: (2022-06-01)
by: Isabelle Bonnet, et al.
Published: (2022-06-01)
Impacts of MDR/XDR-TB on the global tuberculosis epidemic: Challenges and opportunities
by: Kai Ling Chin, et al.
Published: (2024-01-01)
by: Kai Ling Chin, et al.
Published: (2024-01-01)
Drug-resistant tuberculosis: an experience from Qatar
by: Maisa Ali, et al.
Published: (2020-01-01)
by: Maisa Ali, et al.
Published: (2020-01-01)
The Effect of Main Bronchus Stump Closure Method on the Incidence of Stump Failure during Pneumonectomy for Tuberculosis
by: D. B. Giller, et al.
Published: (2024-10-01)
by: D. B. Giller, et al.
Published: (2024-10-01)
Knowledge About Tuberculosis and Multi-Drug Resistant Tuberculosis Among Interns
by: Rupali A Patel, et al.
Published: (2014-03-01)
by: Rupali A Patel, et al.
Published: (2014-03-01)
New drugs and perspectives for new anti-tuberculosis regimens☆
by: S. Tiberi, et al.
Published: (2018-03-01)
by: S. Tiberi, et al.
Published: (2018-03-01)
TB financing in East Europe promotes unnecessary hospital admissions: the case of Armenia
by: Laura Gillini, et al.
Published: (2013-03-01)
by: Laura Gillini, et al.
Published: (2013-03-01)
Issues of Tuberculosis Drug-Resistance in Kharkiv Region and in Ukraine
by: O.S. Shevchenko, et al.
Published: (2019-11-01)
by: O.S. Shevchenko, et al.
Published: (2019-11-01)
Genomic characterization of MDR/XDR-TB in Kazakhstan by a combination of high-throughput methods predominantly shows the ongoing transmission of L2/Beijing 94–32 central Asian/Russian clusters
by: B. J. Klotoe, et al.
Published: (2019-06-01)
by: B. J. Klotoe, et al.
Published: (2019-06-01)
Pneumonectomy in the treatment of tuberculosis relapse in a previously resected lung
by: D. B. Giller, et al.
Published: (2020-06-01)
by: D. B. Giller, et al.
Published: (2020-06-01)
Predominance of Beijing lineage among pre-extensively drug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis: A tertiary care center experience
by: Syed Beenish Rufai, et al.
Published: (2016-01-01)
by: Syed Beenish Rufai, et al.
Published: (2016-01-01)
Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens?
by: E. Pontali, et al.
Published: (2024-11-01)
by: E. Pontali, et al.
Published: (2024-11-01)
Exploring health care providers’ engagement in prevention and management of multidrug resistant Tuberculosis and its factors in Hadiya Zone health care facilities: qualitative study
by: Bereket Aberham Lajore, et al.
Published: (2024-04-01)
by: Bereket Aberham Lajore, et al.
Published: (2024-04-01)
The role of thoracoscopic pneumonectomy in surgical treatment of lung diseases
by: V. A. Porkhanov, et al.
Published: (2019-02-01)
by: V. A. Porkhanov, et al.
Published: (2019-02-01)
Tailored treatment for tuberculosis in transgender individuals: a call for a patient-centered approach from a large Italian cohort
by: Niccolò Riccardi, et al.
Published: (2024-01-01)
by: Niccolò Riccardi, et al.
Published: (2024-01-01)
THE SURGICAL TREATMENT OF BRONCHO-PLEURAL COMPLICATIONS AFTER PNEUMONECTOMIES
by: O. S. Kesaev, et al.
Published: (2012-06-01)
by: O. S. Kesaev, et al.
Published: (2012-06-01)
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial
by: S. B. Patil, et al.
Published: (2023-11-01)
by: S. B. Patil, et al.
Published: (2023-11-01)
Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen <i>Mycobacterium tuberculosis</i>
by: Giuseppe Mancuso, et al.
Published: (2023-09-01)
by: Giuseppe Mancuso, et al.
Published: (2023-09-01)
Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy
by: L. Kuksa, et al.
Published: (2025-03-01)
by: L. Kuksa, et al.
Published: (2025-03-01)
Delamanid in the Treatment of MDR/pre-XDR TB in Arkhangelsk Region in 2019–2021
by: E. S. Khimova, et al.
Published: (2023-07-01)
by: E. S. Khimova, et al.
Published: (2023-07-01)
Computational analysis of RNA methyltransferase Rv3366 as a potential drug target for combating drug-resistant Mycobacterium tuberculosis
by: Tasmin Nazim, et al.
Published: (2024-01-01)
by: Tasmin Nazim, et al.
Published: (2024-01-01)
The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis
by: Heidary M, et al.
Published: (2019-11-01)
by: Heidary M, et al.
Published: (2019-11-01)
Tuberculosis extremadamente resistente (TB-XDR), historia y situación actual
by: Alberto Mendoza Ticona, et al.
Published: (2018-06-01)
by: Alberto Mendoza Ticona, et al.
Published: (2018-06-01)
Extensively drug resistant tuberculosis in Mali: a case report
by: Bassirou Diarra, et al.
Published: (2017-11-01)
by: Bassirou Diarra, et al.
Published: (2017-11-01)
THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)
Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond
by: L. D’Ambrosio, et al.
Published: (2018-03-01)
by: L. D’Ambrosio, et al.
Published: (2018-03-01)
XDR TB in South Africa - What lies ahead?
by: V. Thaver, et al.
Published: (2007-12-01)
by: V. Thaver, et al.
Published: (2007-12-01)
Drug resistance pattern of M. tuberculosis in category II treatment failure pulmonary tuberculosis patients
by: Fahmida Rahman, et al.
Published: (2013-01-01)
by: Fahmida Rahman, et al.
Published: (2013-01-01)
Drug-Resistant Tuberculosis, KwaZulu-Natal, South Africa, 2001–2007
by: Kristina Wallengren, et al.
Published: (2011-10-01)
by: Kristina Wallengren, et al.
Published: (2011-10-01)
THE ROLE OF THE IMPLANTABLE PORT SYSTEM FOR THE CENTRAL VENOUS ACCESS IN TREATMENT OF PULMONARY TUBERCULOSIS WITH MULTIPLE AND EXTENSIVELY DRUG RESISTANCE (PRELIMINARY RESULTS)
by: О.R. RAZAKOV, et al.
Published: (2018-08-01)
by: О.R. RAZAKOV, et al.
Published: (2018-08-01)
Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
by: Andrey Maryandyshev, et al.
Published: (2017-10-01)
by: Andrey Maryandyshev, et al.
Published: (2017-10-01)
Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
by: Jaksuwan R, et al.
Published: (2017-06-01)
by: Jaksuwan R, et al.
Published: (2017-06-01)
COMPARATIVE ANALYSIS OF MTB STRAINS WITH DIFFERENT TYPES OF DRUG RESISTANCE IN PULMONARY TUBERCULOSIS IN THE KYRGYZ REPUBLIC
by: A.A. TOKTOGONOVA, et al.
Published: (2018-08-01)
by: A.A. TOKTOGONOVA, et al.
Published: (2018-08-01)
Similar Items
-
Prevention of bronchial fistulas after pneumonectomies for selected cavitary drug resistant lung tuberculosis
by: Alexander V. Bazhenov, et al.
Published: (2023-03-01) -
Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort studyResearch in context
by: Yousra Kherabi, et al.
Published: (2025-09-01) -
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
by: Viola Dreyer, et al.
Published: (2022-08-01) -
Pretomanid for tuberculosis treatment: an update for clinical purposes
by: Sara Occhineri, et al.
Published: (2022-01-01) -
Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil
by: Tania Matsui, et al.
Published: (2020-05-01)
